Severe neonatal hyperbilirubinaemia: lessons learnt from a national perinatal audit

• Published in: Archives of disease in childhood. Fetal and neonatal edition Vol. 107; no. 5; pp. 527 - 532
• Main Authors: van der Geest, Berthe A M, Rosman, Ageeth N, Bergman, Klasien A, Smit, Bert J, Dijk, Peter H, Been, Jasper V, Hulzebos, Christian V
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health 01.09.2022; BMJ Publishing Group LTD
• Subjects: audit; Audits; Birth weight; Blood groups; Breastfeeding & lactation; Documentation; Gestational age; Health care; Hospitals; Jaundice; Laboratories; Light therapy; Maternal child nursing; Medical records; Meetings; Midwifery; Neonatal care; Neonates; neonatology; Newborn babies; Obstetrics; Original research; Pediatrics; Primary care; Risk assessment; Risk factors; Transfusion; Netherlands; neonatology; audit; jaundice
• ISSN: 1359-2998; 1468-2052
• DOI: 10.1136/archdischild-2021-322891

ObjectivesTo describe characteristics of neonates with severe neonatal hyperbilirubinaemia (SNH) and to gain more insight in improvable factors that may have contributed to the development of SNH.Design and settingDescriptive study, based on national Dutch perinatal audit data on SNH from 2017 to 2019.PatientsNeonates, born ≥35 weeks of gestation and without antenatally known severe blood group incompatibility, who developed hyperbilirubinaemia above the exchange transfusion threshold.Main outcome measuresCharacteristics of neonates having SNH and corresponding improvable factors.ResultsDuring the 3-year period, 109 neonates met the eligibility criteria. ABO antagonism was the most frequent cause (43%). All neonates received intensive phototherapy and 30 neonates (28%) received an exchange transfusion. Improvable factors were mainly related to lack of knowledge, poor adherence to the national hyperbilirubinaemia guideline, and to incomplete documentation and insufficient communication of the a priori hyperbilirubinaemia risk assessment among healthcare providers. A priori risk assessment, a key recommendation in the national hyperbilirubinaemia guideline, was documented in only six neonates (6%).ConclusionsSNH remains a serious threat to neonatal health in the Netherlands. ABO antagonism frequently underlies SNH. Lack of compliance to the national guideline including insufficient a priori hyperbilirubinaemia risk assessment, and communication among healthcare providers are important improvable factors. Implementation of universal bilirubin screening and better documentation of the risk of hyperbilirubinaemia may enhance early recognition of potentially dangerous neonatal jaundice.